OGI Bio is pleased to announce the successful extension of its seed funding round, securing nearly £500,000 to support the next phase of its growth. This additional investment will enable the company to further accelerate the development of its microbial culturing automation systems, scale production, and expand its team.
The extended funding round includes contributions from existing investors, as well as new backers, reflecting strong confidence in OGI Bio’s potential to revolutionize the biotech industry.
“We are incredibly grateful for the continued support from our investors,” said Stephen Roe, Chair of OGI Bio. “This funding will allow us to build on our progress and bring our innovative solutions to more researchers worldwide.”
With this extension, OGI Bio is poised to make significant strides in transforming the way scientific research is conducted, enhancing efficiency, accessibility, and productivity across the biotechnology sector.